Who Paid My Doc
Lisa Raptis
Hospice and Palliative Medicine Pomona, CA Medical Doctor
NPI 1902073802 CMS profile 844323
1866 N Orange Grove Ave Ste 202, Pomona, CA 91767
General payments
$126
Research payments
$0
Ownership & investment interest
$0
Through program year 2020, Lisa Raptis of Pomona, CA is reported in the CMS Open Payments database as having received $126 across 4 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
By program year
2 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2020 | General | $59 | 3 | |
| 2019 | General | $68 | 1 |
Beside peers
- Lisa Raptis
- Hospice and Palliative Medicine median
- Middle half of Hospice and Palliative Medicine
- National median
In program year 2024, general payments to Lisa Raptis were reported at $0. Among 22 Hospice and Palliative Medicine profiles paid that year, the median was $119 and the middle half received between $44 and $165.
Show as a table
| Year | Lisa Raptis | Hospice and Palliative Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $68 | $49 | $16–$122 | $163 |
| 2020 | $59 | — | — | $114 |
| 2021 | $0 | — | — | $132 |
| 2022 | $0 | $30 | $18–$119 | $149 |
| 2023 | $0 | — | — | $160 |
| 2024 | $0 | $119 | $44–$165 | $164 |
| 2025 | $0 | — | — | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 5 billing codesPaid by Medicare
$213,832
Medicare patients
391
Services billed
2,006
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Diabetes | 57% | |
| Heart failure | 57% | |
| Chronic kidney disease | 52% | |
| Ischemic heart disease | 50% | |
| Alzheimer's or dementia | 47% | |
| Atrial fibrillation | 43% | |
| Arthritis | 38% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
4 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Hospice and Palliative Medicine in California
Susan Stone
Hospice and Palliative Medicine · Torrance, CA
David Wang
Hospice and Palliative Medicine · San Diego, CA
Marla Gandara
Hospice and Palliative Medicine · Burbank, CA
Larry Foreman
Hospice and Palliative Medicine · San Luis Obispo, CA
Maria De Lourdes Sturchler
Hospice and Palliative Medicine · San Diego, CA
Joseph Vega
Hospice and Palliative Medicine · Duarte, CA
Related records
Hospice and Palliative Medicine in California
Practitioners in the same specialty and state, ranked by reported value.
All Hospice and Palliative Medicine
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.